Mobidiag

About:

Mobidiag is a Molecular diagnostic company developing and commercializing solutions for the detection of infectious diseases.

Website: http://www.mobidiag.com/

Twitter/X: mobidiag

Top Investors: European Investment Bank, Business Finland, Springvest, Autobio Diagnostics

Description:

Mobidiag is a commercial stage, fast-growing Finnish-French biotechnology company that develops and markets innovative molecular diagnostic solutions for gastrointestinal infections, antimicrobial resistance management, healthcare associated infections (HAIs), respiratory infections and sepsis. Based on well-established qPCR and microarray technologies, Mobidiag offers a broad range of tests and automated platforms. These include a comprehensive range of fast, reliable and cost-effective molecular diagnostic solutions for the detection of infectious diseases adapted to laboratories of all sizes. They allow detection of most clinically relevant bacteria, parasites, viruses and markers for antibiotic resistance.

Total Funding Amount:

$74.1M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Espoo, Southern Finland, Finland

Founded Date:

2000-01-01

Contact Email:

sales(AT)mobidiag.com

Founders:

Mart Saarma

Number of Employees:

51-100

Last Funding Date:

2020-01-07

IPO Status:

Private

Industries:

© 2025 bioDAO.ai